Literature DB >> 28495638

Targeting metabolism in pancreatic cancer.

Christoph W Michalski1, Thilo Hackert1, Markus W Büchler2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28495638     DOI： 10.1016/S1470-2045(17)30304-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

Review 1.  Upper gastrointestinal malignancies in 2017: current perspectives and future approaches.

Authors:  Benjamin L Solomon; Ignacio Garrido-Laguna
Journal:  Future Oncol       Date:  2018-03-15       Impact factor: 3.404

2.  Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer.

Authors:  Fan Yang; Dong-Yan Liu; Jin-Tao Guo; Nan Ge; Ping Zhu; Xiang Liu; Sheng Wang; Guo-Xin Wang; Si-Yu Sun
Journal:  World J Gastroenterol       Date:  2017-12-21       Impact factor: 5.742

3.  Natural Compound Methyl Protodioscin Suppresses Proliferation and Inhibits Glycolysis in Pancreatic Cancer.

Authors:  LianYu Chen; Chien-Shan Cheng; HuiFeng Gao; Ling Zhan; FengJiao Wang; Chao Qu; Ye Li; Peng Wang; Hao Chen; ZhiQiang Meng; LuMing Liu; HaiFeng Chen; Zhen Chen
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-15       Impact factor: 2.629

4.  Integrated transcriptomic analysis reveals hub genes involved in diagnosis and prognosis of pancreatic cancer.

Authors:  Yang-Yang Zhou; Li-Ping Chen; Yi Zhang; Sun-Kuan Hu; Zhao-Jun Dong; Ming Wu; Qiu-Xiang Chen; Zhi-Zhi Zhuang; Xiao-Jing Du
Journal:  Mol Med       Date:  2019-11-09       Impact factor: 6.354
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.